Chief financial officer

Annual Results 2022

Retrieved on: 
Monday, April 17, 2023

In 2022, Charwood Energy enjoyed strong sales momentum with the roll-out of new projects on behalf of third parties, despite a delay in the implementation of certain biomass power plant projects, now set for 2023.

Key Points: 
  • In 2022, Charwood Energy enjoyed strong sales momentum with the roll-out of new projects on behalf of third parties, despite a delay in the implementation of certain biomass power plant projects, now set for 2023.
  • Overall, revenue amounted to €4.9m in 2022 vs. €4.6m in 2021.
  • To prepare for its future growth, Charwood Energy has structured its teams across all key functions, increasing its workforce from 25 people in 2021 to 40 people in 2022.
  • by 2027, revenue of €100m, and 50 power plants owned, in operation or under construction, representing an ARR [2] of around €90m.

CROSSTEC Group (3893.HK) Appoints Chief Executive Officer

Retrieved on: 
Wednesday, March 8, 2023

HONG KONG, Mar 8, 2023 - (ACN Newswire) - CROSSTEC Group Holdings Limited (HKEX stock code: 3893) has officially appointed Mr. Lam Wing Hung as the Chief Executive Officer with effect from 13 March 2023, this change follows Mr. Lam's appointment as Acting Chief Executive Officer in the last three months.

Key Points: 
  • HONG KONG, Mar 8, 2023 - (ACN Newswire) - CROSSTEC Group Holdings Limited (HKEX stock code: 3893) has officially appointed Mr. Lam Wing Hung as the Chief Executive Officer with effect from 13 March 2023, this change follows Mr. Lam's appointment as Acting Chief Executive Officer in the last three months.
  • Mr. Lam currently is an Executive Director of the Group, the Finance Director and the joint Company Secretary of the Company.
  • Mr. Lam Wing Hung, joined the Group as Financial Controller in April 2017.
  • He has been appointed as an Executive Director and promoted to Finance Director of the Company with effect from 16 September 2022.

Andrea Bendzick Promoted to President and CEO of Astreya

Retrieved on: 
Friday, March 3, 2023

SAN JOSE, Calif., March 3, 2023 /PRNewswire/ -- Astreya, a leading provider of IT-managed services, is pleased to announce the promotion of Andrea Bendzick to the position of President and CEO.

Key Points: 
  • SAN JOSE, Calif., March 3, 2023 /PRNewswire/ -- Astreya, a leading provider of IT-managed services, is pleased to announce the promotion of Andrea Bendzick to the position of President and CEO.
  • Since taking on the role of President in February 2022, Bendzick has overseen Astreya's strategic direction, services portfolio, and global expansion efforts in key international markets.
  • Under her tenure as President, Astreya has achieved strong double-digit  growth and acquired several new, prominent clients.
  • Astreya's Chairman, Jeffrey Freeland, said, "We are thrilled to have Andrea Bendzick assume the President & CEO role.

BTB REIT Announces the Appointment of Mathieu Bolté as Executive Vice-President, Chief Operating and Financial Officer

Retrieved on: 
Monday, February 27, 2023

MONTRÉAL, Feb. 27, 2023 /CNW/ - BTB Real Estate Investment Trust (TSX: BTB.UN) ("BTB" or the "REIT") announces the appointment of Mathieu Bolté as Executive Vice-President, Chief Operating and Financial Officer.

Key Points: 
  • MONTRÉAL, Feb. 27, 2023 /CNW/ - BTB Real Estate Investment Trust (TSX: BTB.UN) ("BTB" or the "REIT") announces the appointment of Mathieu Bolté as Executive Vice-President, Chief Operating and Financial Officer.
  • On February 24, 2023, BTB's Board of Trustees unanimously accepted this appointment, effective March 1, 2023.
  • Since May 2020, Mr. Bolté has assumed the functions and responsibilities of Vice-President and Chief Financial Officer of BTB.
  • This new appointment solidifies the organizational structure of BTB while opening the door to new fields of action.

Data I/O Reports Fourth Quarter 2022 Results

Retrieved on: 
Thursday, February 23, 2023

For the fifth consecutive quarter, we achieved bookings in excess of $6.0 million, with fourth quarter 2022 bookings of $6.8 million reaching the highest level for the fourth quarter since 2019.

Key Points: 
  • For the fifth consecutive quarter, we achieved bookings in excess of $6.0 million, with fourth quarter 2022 bookings of $6.8 million reaching the highest level for the fourth quarter since 2019.
  • Fourth quarter 2022 bookings were $6.8 million, up from $6.2 million in the fourth quarter 2021.
  • R&D expenses were $1.5 million in the fourth quarter of 2022 compared to $1.6 million in the fourth quarter of the prior year.
  • Included in net loss are foreign currency transaction losses of ($156,000) for the fourth quarter of 2022 and ($138,000) for the fourth quarter of 2021.

Olema Oncology to Participate at Upcoming Investor Conferences

Retrieved on: 
Tuesday, February 21, 2023

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences:

Key Points: 
  • SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences:
    Sean Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at Citi’s 2023 Virtual Oncology Leadership Summit on Thursday, February 23, 2023, at 12:00 p.m.
  • ET.
  • Shane Kovacs, Chief Operating and Financial Officer, will participate in the Breast and Lung Cancer Corporate Panel at Cowen’s 43rd Annual Healthcare Conference on Tuesday, March 7, 2023, at 10:30 a.m.
  • A live webcast of these events will be available under the News & Events section of Olema’s Investor Relations website at www.olema.com and will be archived for at least 30 days.

Carbon America Welcomes Chief Commercial and Financial Officer Cruz Gamboa and COO Craig Spreadbury, As the Company Continues Growth

Retrieved on: 
Tuesday, January 24, 2023

In December, Cruz Gamboa was named Chief Commercial and Financial Officer, and Craig Spreadbury started as Chief Operating Officer.

Key Points: 
  • In December, Cruz Gamboa was named Chief Commercial and Financial Officer, and Craig Spreadbury started as Chief Operating Officer.
  • “We are very excited to welcome Cruz and Craig to Carbon America at this important time of growth for us,” said Brent Lewis, CEO at Carbon America.
  • “The opportunities in Carbon Capture and Sequestration are rapidly expanding and Carbon America is uniquely positioned to lead this space,” Gamboa said.
  • In 2022, Carbon America announced its first agreements to finance, build, own and operate carbon capture and sequestration systems.

Torrid Holdings Inc. Investors: Please contact the Portnoy Law Firm to recover your losses, January 17, 2023 deadline

Retrieved on: 
Thursday, January 12, 2023

LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Torrid Holdings Inc. (“Torrid” or “the Company”) (NYSE: CURV) investors that a lawsuit filed on behalf of investors that purchased securities traceable to the Company’s July 2021 initial public offering. Torrid investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • Torrid investors are encouraged to contact the firm to discuss their legal rights.
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 844-767-8529 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

Convergent Energy and Power Releases 2022 Sustainability and Impact Report

Retrieved on: 
Monday, January 9, 2023

Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the publication of its 2022 Sustainability and Impact Report .

Key Points: 
  • Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the publication of its 2022 Sustainability and Impact Report .
  • I’m proud of the progress we’ve made and excited for the path we have charted in our 2022 Sustainability and Impact Report,” said Johannes Rittershausen, Convergent’s CEO.
  • As of February 2022, Sustainalytics rated Convergent as the ninth lowest risk out of the 676 companies they rated within the utilities sector.
  • Over 50% of the energy storage systems Convergent originated in the past 24 months include solar PV.

Tactile Medical Appoints Carmen Volkart to Board of Directors

Retrieved on: 
Thursday, January 5, 2023

MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company’s Board of Directors (“Board”), effective January 5, 2023.

Key Points: 
  • MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Carmen Volkart to the Company’s Board of Directors (“Board”), effective January 5, 2023.
  • “Carmen joins our Board with more than 40 years of experience in financial and managerial positions, including extensive experience leading medical device companies,” said Bill Burke, Chairman of the Board of Tactile Medical.
  • “We are glad to welcome Carmen to Tactile Medical and look forward to benefiting from her operating expertise and strategic insight.”
    Since 2018, Carmen Volkart has served as the Chief Financial Officer of NatureWorks LLC, a privately-held advanced materials company and developer of renewably sourced polymers and chemicals.
  • From 2004 to 2006, Ms. Volkart served as Executive Vice President, and Chief Financial Officer of American Medical Systems, Inc., a publicly traded medical device company focused on male and female pelvic health.